SAN FRANCISCO — CIBC Innovation Banking has provided $40 million in growth capital financing to Viz.ai. The funding will help expand the company’s AI-powered care coordination platform and potential acquisitions.
Viz.ai uses artificial intelligence to expedite disease detection, inform critical care decisions and help improve patient care. The Viz.ai AI-powered platform helps connect and activate entire care teams, including radiologists, emergency physicians, and specialists to optimize care pathways and increase patient access to life-saving treatments.
“Today, Viz.ai serves a patient every 21 seconds across more than 1,300 hospitals. With CIBC Innovation Banking’s investment, we will evaluate strategic acquisition opportunities and reach and impact even more patients by expanding our end-to-end platform into new disease areas,” said Lisa Garland, VP of Finance, Viz.ai.
“We are delighted to support Viz.ai through its rapid growth,” said Jeff Chapman, Head of North American Life Science and Healthcare, CIBC Innovation Banking. “The company’s transformation of disease detection and workflow optimization for healthcare systems has propelled them to become a leader in the industry. CIBC Innovation Banking is proud to be involved in Viz.ai’s exciting journey ahead.”
Viz.ai is also backed by venture capital investors including Insight Partners, Tiger Global, Kleiner Perkins, Google Ventures, Scale Venture Partners, and Greenoaks Capital Partners.
